← All organizations

Stemcentrx

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 1, 2016

Acquired by AbbVie on Apr 28, 2016

Timeline

2000s

Jun 1, 2008
Stemcentrx— Founded

2010s

Apr 28, 2016
AbbVie— Acquired By

Drugs by trial phase (5 distinct, 7 trials)

Phase 2 (1 own, 0 via acquisition)

rovalpituzumab tesirine

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT02819999Lead sponsorPhase 1Oct 1, 2016
NCT02819999Study directorPhase 1Oct 1, 2016
NCT02874664Study directorPhase 1Sep 1, 2016
NCT02709889Study directorPhase 1/Phase 2Sep 1, 2016
NCT02709889Lead sponsorPhase 1/Phase 2Sep 1, 2016
NCT02874664Lead sponsorPhase 1Sep 1, 2016
NCT02674568Lead sponsorPhase 2Mar 8, 2016
NCT02674568Study directorPhase 2Mar 8, 2016
NCT02539719Lead sponsorPhase 1Aug 1, 2015
NCT02500914Lead sponsorPhase 1Jun 1, 2015
NCT01901653Lead sponsorPhase 1/Phase 2Jul 1, 2013

Details

Founded: South San Francisco, CA, US Jun 1, 2008
Last known activity: Oct 1, 2016